Approaches in Immunotherapy, Regenerative Medicine, and Bioengineering for Type 1 Diabetes

Explore this paper's citation graph

Summary

Integrating immunotherapy, stem cell-mediated β-cell or islet production and bioengineering to interface with the patient is expected to lead to a durable cure or pave the way for a clinical solution for T1DM.

Type
article
Published
2018-06-12
Cited by
22
References
159
Access
Open access

Keywords

Physical activity, Computer science, Medicine, Physical medicine and rehabilitation

References

Cited by

Related papers